AL
BIO icon

Airain Ltd’s Bio-Rad Laboratories Class A BIO Stock Holding History

Airain Ltd’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-2,895
Closed -$349K – 827
2014
Q4 		$349K Buy
+2,895
New +$333K 0.03% 464
2014
Q3 		– Sell
-2,447
Closed -$293K – 800
2014
Q2 		$293K Buy
+2,447
New +$299K 0.02% 552
2013
Q3 		– Sell
-3,873
Closed -$435K – 479
2013
Q2 		$435K Buy
+3,873
New +$454K 0.06% 293

Other funds holding BIO

ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
NIMC
NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Airain Ltd's BIO Position: Q1 2015 in Review

Airain Ltd sold out of Bio-Rad Laboratories Class A (BIO) in Q1 2015, closing a stake of 2,895 shares — an estimated $349K sold.

Airain Ltd first reported a position in BIO in Q2 2013 and held it in 3 quarters. The position peaked at $435K in Q2 2013. 219 funds tracked by Wall St. Rank hold BIO as of Q1 2015.

  • Airain Ltd reported no remaining Bio-Rad Laboratories Class A position as of Q1 2015 after selling out during the quarter.
  • Airain Ltd sold 2,895 Bio-Rad Laboratories Class A shares in Q1 2015, an estimated $349K.
  • Airain Ltd first reported a position in Bio-Rad Laboratories Class A in Q2 2013 and held it in 3 quarters.
  • Airain Ltd's Bio-Rad Laboratories Class A position peaked at $435K in Q2 2013.
  • 219 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q1 2015.

Based on Airain Ltd's 13F filing for Q1 2015, filed 11 May 2015.